Clinical Observation of Integrated Medicine Therapy in Ulcerative Colitis
LI Sheng-x
Abstract
LI Sheng-x
Abstract
Objective:To explore the clinical efficacy of integrated medicine in patients with ulcerative colitis. Method:80 ulcerative colitis patients from August 2011 to August 2013 were selected and randomly divided into observation group and control group,each group contained 40 cases. The control group was separately assigned sulfasalazine pyridine,the observation group was given integrated medicine treatment. The clinical efficacy were compared between the two groups. Result:The total effective rate of the observation group was 97.5%,while the total effective rate of control group was 85.0%. The total effective rate of observation group was significantly higher than that of the control group,the difference was statistically significant(P0.05). Conclusion:Integrated medicine in the treatment of ulcerative colitis has a significant effect. It can rapidly improve the clinical symptoms. It is worth for clinical application and promotion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the clinical efficacy of integrated medicine in patients with ulcerative colitis. Method:80 ulcerative colitis patients from August 2011 to August 2013 were selected and randomly divided into observation group and control group,each group contained 40 cases. The control group was separately assigned sulfasalazine pyridine,the observation group was given integrated medicine treatment. The clinical efficacy were compared between the two groups. Result:The total effective rate of the observation group was 97.5%,while the total effective rate of control group was 85.0%. The total effective rate of observation group was significantly higher than that of the control group,the difference was statistically significant(P0.05). Conclusion:Integrated medicine in the treatment of ulcerative colitis has a significant effect. It can rapidly improve the clinical symptoms. It is worth for clinical application and promotion.
Key concepts: Ulcerative colitis, Medicine, Sulfasalazine, Internal medicine, Gastroenterology, Clinical efficacy, Disease